（苏农银行） 1月21日，苏农银行发布2025年业绩快报。业绩快报显示，截至2025年末，苏农银行总资产2311.03亿元，较年初增长 8.00%；总贷款1394.32亿元，较年初增长7.81%；总存款1829.59亿元，较年初增长7.47%，其中储蓄存款1125.12亿 元，较年初增长11.03%。2025年度实现营业收入41.91亿元，同比增长0.41%；归属于母公司股东的净利润20.43亿元， 同比增长5.04%。截至2025年末，该行不良贷款率0.88%，较年初下降0.02个百分点，关注贷款率1.33%，拨备覆盖率 370.19%，资产质量健康稳健。 ...

《科创板日报》22日讯，1月23日至24日，第三届北京商业航天产业高质量发展推进会将在北京经开区举办。本次大 会以"聚力赋新 质向空天"为主题，将设置成果发布、主旨报告、专题座谈等多个环节，邀请政府部门、航天院所、领 军企业及金融机构等多方代表参与，共探技术变革新趋势、共绘产业发展新图景。东方证券表示，"十五五"规划落地 后，关注无人与反无人装备、深海科技、作战信息化等为代表的新质生产力；中长期来看，关注军工企业在民用两机 业务和商业航天的广阔发展空间，以及中式高端装备出海提速下军贸市场的拓展，民用及军贸有望成为板块的第二增 长极。此外在低空经济一侧，天风证券观点显示，政策层面深圳"十五五"规划前瞻布局低空运营设施，国家能源局部 署高质量充电基础设施体系建设，为通用航空发展提供政策支撑与基础设施保障；板块层面，通用航空作为高端制造 重要细分领域，受益于低空经济政策红利及消费升级趋势，行业成长空间广阔。通用航空ETF南方(159283.SZ)跟踪中 证通用航空主题指数，指数精选包括但不限于航空材料、飞行器制造等细分领域优质企业，可全面覆盖产业链相关企 业，布局机遇可关注。 1月22日，沪深两市震荡上行，低空经济 ...

Core Insights - The article discusses the global launch event of Beijing Chuanruizer Manned Space Technology Co., Ltd. (referred to as "Chuanruizer") for space tourism, highlighting the strategic partnership with outdoor brand Tantuo to create a "space + outdoor" ecosystem [1][5] - Chuanruizer aims to achieve suborbital manned commercial space tourism by 2028, near-Earth orbital tourism by 2032, and lunar orbit travel by 2038 [1] - The event featured the first group of space tourists, including notable figures from various industries, emphasizing the collaboration between Chuanruizer and Tantuo in developing space-related technologies and products [1][2] Group 1: Strategic Partnership and Goals - Chuanruizer and Tantuo announced a strategic cooperation to integrate aerospace technology with outdoor and chip industries, aiming to build an innovative ecosystem [1] - Tantuo will provide space suits and explore applications of chip technology, smart equipment, brain-machine interface technology, and wearable exoskeleton robots in commercial space [1][3] - The partnership includes the establishment of a microgravity human efficacy center to research space suit materials and new composite materials for outdoor use [3] Group 2: Technological Innovations and Products - Tantuo showcased various smart outdoor products at the event, including an intelligent outdoor exoskeleton and smart outdoor watches, highlighting advancements in China's outdoor smart product sector [4] - The intelligent outdoor exoskeleton utilizes deep learning algorithms to enhance motion recognition and reduce muscle fatigue, with significant improvements in battery life and waterproof performance [4] - Tantuo's dual business strategy of "outdoor + chip" marks a shift from product innovator to ecosystem builder, supported by recent acquisitions and product launches [4][5] Group 3: Market Potential and Future Outlook - The Chinese commercial space market is expected to reach a scale of 7 trillion to 10 trillion yuan by 2030, indicating significant growth potential [5] - The strategic collaboration between Chuanruizer and Tantuo is seen as a timely response to industry trends and a bold exploration of technological innovation boundaries [5] - The partnership aims to integrate aerospace technology into outdoor life, contributing to the development of high-end manufacturing and emerging industries in China [5]

（企业公告） 1月22日，ST绝味发布公告称，公司预计2025年度实现营业收入53亿元到55亿元，同比下降12.09%到 15.29%；实现净亏损1.6亿至2.2亿元，与上年同期相比，将出现亏损。 报告期内公司经营持续承压，本期营业收入有所下降，生产产能未充分释放，多方面因素综合影响导致 利润下降。另外，营业外支出事项增加以及权益法核算下投资亏损，进而对公司本期业绩变动造成较大 影响。 (编辑：王璨 林辰)关键字： 食品 绝味食品 ...

Core Insights - The company is undergoing a significant transformation in its organizational structure and marketing strategy to enhance operational efficiency and market responsiveness [2][3][4]. Group 1: Strategic Positioning - The company has shifted its strategic focus from "pan-nationalization" to "regional market gradient cultivation," aiming for high-quality development and stable growth [2]. - A clear product structure and pricing strategy have been established, emphasizing a "value for money" product value system [2]. Group 2: Brand and Marketing Strategy - The company has clarified its brand core value positioning and is focusing on major product lines, particularly the "Jinsha Huisha" brand [2][3]. - The marketing strategy is transitioning from traditional advertising to content and scenario marketing, with a focus on deepening market engagement [2][3]. Group 3: Organizational Changes - The organizational structure is being upgraded from a three-tier system to a more agile "functional department + regional division" model, allowing for faster decision-making and resource allocation [3]. - The company is implementing a performance evaluation system centered on terminal sales, moving away from traditional inventory-focused metrics [3][4]. Group 4: Operational Improvements - A comprehensive tracking system for product flow is being established to maintain market order and pricing stability [4]. - The company is adopting a "short-term stop - mid-term control - long-term efficiency" strategy for expense management, linking spending directly to market outcomes [4]. Group 5: Market and Terminal Operations - The company is implementing a tiered operational strategy for core, key, and general markets to optimize resource allocation [5]. - There is a focus on enhancing terminal cooperation quality and conversion efficiency through improved assessment and service processes [5]. Group 6: Team and Policy Development - The company is reforming its compensation and evaluation systems to better align performance with process indicators, thereby activating team potential [5]. - A unified and simplified national market policy is being established to ensure effective brand marketing [5].

经国家认可的专业第三方检测机构严格检测，润科生物ARA（花生四烯酸油脂）、DHA（二十二碳六 烯酸）产品均未检出蜡样芽孢杆菌呕吐毒素，符合国际相关安全标准。 公司每年接受大量监管部门的飞行检查，对包括但不限于蜡样芽孢杆菌在内的风险指标实施长期持续监 控，确保每一批次产品均可追溯、品质可靠。 （企业公众号） 1月22日，润科官方公众号发布润科ARA、DHA产品均未检出蜡样芽孢杆菌呕吐毒素的消息。当中介 绍，近期某奶粉召回事件引起市场及消费者对ARA（花生四烯酸）、DHA（二十二碳六烯酸）安全性 的相关讨论。我司对此高度重视，并始终将产品质量与消费者健康置于首位。现就润科生物ARA、 DHA产品安全性做出郑重声明： ...

(编辑：王璨 林辰) 近日，有传闻称元气森林正在考虑于港股上市。对此，元气森林相关负责人表示，目前元气森林没有上 市计划。 （企业回应） ...

（港交所官网披露易） (编辑：杨燕 林辰) 近日，普祺医药向香港联交所主板递交上市申请书，中信证券和民银资本担任联席保荐人。 普祺医药是一家专注于免疫炎症领域的生物科技公司，普美昔替尼凝胶为用于治疗特应性皮炎的JAK抑 制剂凝胶，已完成成人及12至17岁青少年特应性皮炎适应症的III期临床试验，并正拓展至2至11岁儿童 特应性皮炎。普美昔替尼鼻喷雾剂为全球首款用于治疗季节性过敏性鼻炎的临床阶段JAK抑制剂鼻喷雾 剂，正处于针对成年人季节性过敏性鼻炎的III期临床试验阶段，并正拓展至青少年季节性过敏性鼻炎及 成年人常年性过敏性鼻炎。 ...

Core Insights - Johnson & Johnson reported Q4 2025 sales of $24.564 billion, a 9.1% increase from $22.52 billion in the same period last year [1] - The company's net profit for Q4 reached $5.116 billion, up 49.1% from $3.431 billion year-over-year [1] - For the full year, total sales were $94.193 billion, a 6% increase from $88.821 billion in the previous year [1] - Annual net profit surged to $26.804 billion, a 90.6% increase from $14.066 billion year-over-year [1] Business Segment Performance - The innovative pharmaceuticals segment generated $15.763 billion in sales for Q4 [1] - The medical technology segment reported sales of $8.801 billion for the same quarter [1] - For the full year, the innovative pharmaceuticals segment achieved sales of $60.401 billion, while the medical technology segment reached $33.792 billion [1]

（复星医药公告） 1月22日，复星医药发布公告称，拟分拆其所属子公司复星安特金（成都）生物制药股份有限公司至香 港联合交易所主板上市。本次分拆完成后，预计不会影响公司对复星安特金的控制权。 ...